Congress funds $250M environmental neurodegenerative disease research program
H.R. 7779 — HEALTHY BRAINS Act of 2026 · Filed by Suhas Subramanyam (D-VA) · 12 cosponsors · Introduced Mar 3, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to establish a research program studying how environmental toxins—such as air pollution, heavy metals, and industrial chemicals—contribute to neurodegenerative diseases like Alzheimer's and Parkinson's. The program will fund research centers at universities and medical institutions to investigate these environmental risk factors, train scientists, and share findings with the public and health professionals. The bill authorizes $50 million per year for five years (2027–2031) to support this research effort.
Why we flagged it
The bill establishes a federally funded research program focused on environmental causes of neurodegenerative disease. It is a straightforward public health investment with no private carve-outs, liability shields, or narrow beneficiaries—routine legislative authorization of research infrastructure.
What the text implies
- The bill's focus on environmental risk factors may implicitly shift public health discourse away from genetic or pharmaceutical interventions toward prevention and environmental remediation, potentially affecting demand for certain therapeutic approaches.
- Establishment of a nationwide data system and clearinghouse creates a centralized repository of environmental health data that could inform future environmental regulations or litigation, with downstream effects on industrial practices.
The full analysis lists 3 implications of this text.
Who stands to gain
universities and medical research institutions (grant recipients); environmental health research contractors and consultants